Steger GG - Search Results

1

Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy.

Rudas M, Filipits M, Taucher S, Stranzl T, Steger GG, Jakesz R, Pirker R, Pohl G. Rudas M, et al. Among authors: steger gg. Breast Cancer Res Treat. 2003 Sep;81(2):149-57. doi: 10.1023/A:1025751631115. Breast Cancer Res Treat. 2003. PMID: 14572157

2

Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy.

Pohl G, Rudas M, Taucher S, Stranzl T, Steger GG, Jakesz R, Pirker R, Filipits M. Pohl G, et al. Among authors: steger gg. Breast Cancer Res Treat. 2003 Mar;78(1):97-103. doi: 10.1023/a:1022165715043. Breast Cancer Res Treat. 2003. PMID: 12611462

3

Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.

Schmid M, Jakesz R, Samonigg H, Kubista E, Gnant M, Menzel C, Seifert M, Haider K, Taucher S, Mlineritsch B, Steindorfer P, Kwasny W, Stierer M, Tausch C, Fridrik M, Wette V, Steger G, Hausmaninger H. Schmid M, et al. J Clin Oncol. 2003 Mar 15;21(6):984-90. doi: 10.1200/JCO.2003.01.138. J Clin Oncol. 2003. PMID: 12637461 Clinical Trial.

4

Impact of pretreatment thrombocytosis on survival in primary breast cancer.

Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, Schmid M, Smola MG, Stierer M, Tausch C, Galid A, Steger G, Jakesz R; Austrian Breast and Colorectal Cancer Study Group. Taucher S, et al. Thromb Haemost. 2003 Jun;89(6):1098-106. Thromb Haemost. 2003. PMID: 12783124

5

Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy.

Brostjan C, Bayer A, Zommer A, Gornikiewicz A, Roka S, Benkö T, Yaghubian R, Jakesz R, Steger G, Gnant M, Friedl J, Stift A. Brostjan C, et al. Cancer. 2003 Nov 15;98(10):2291-301. doi: 10.1002/cncr.11776. Cancer. 2003. PMID: 14601101 Free article. Clinical Trial.

6

Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.

Taucher S, Rudas M, Mader RM, Gnant M, Sporn E, Dubsky P, Roka S, Bachleitner T, Fitzal F, Kandioler D, Wenzel C, Steger GG, Mittlböck M, Jakesz R. Taucher S, et al. Among authors: steger gg. Breast Cancer Res Treat. 2003 Dec;82(3):207-13. doi: 10.1023/B:BREA.0000004378.15859.51. Breast Cancer Res Treat. 2003. PMID: 14703068

7

Monitoring of serum Her-2/neu predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer.

Köstler WJ, Schwab B, Singer CF, Neumann R, Rücklinger E, Brodowicz T, Tomek S, Niedermayr M, Hejna M, Steger GG, Krainer M, Wiltschke C, Zielinski CC. Köstler WJ, et al. Among authors: steger gg. Clin Cancer Res. 2004 Mar 1;10(5):1618-24. doi: 10.1158/1078-0432.ccr-0385-3. Clin Cancer Res. 2004. PMID: 15014012

8

Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer.

Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Roka S, Bachleitner T, Kandioler D, Steger G, Mittlböck M, Jakesz R. Taucher S, et al. Wien Klin Wochenschr. 2004 Jan 31;116(1-2):26-31. doi: 10.1007/BF03040420. Wien Klin Wochenschr. 2004. PMID: 15030120

9

Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer.

Köstler WJ, Steger GG, Soleiman A, Schwab B, Singer CF, Tomek S, Brodowicz T, Krainer M, Wiltschke C, Horvat R, Jakesz R, Zielinski CC. Köstler WJ, et al. Among authors: steger gg. Anticancer Res. 2004 Mar-Apr;24(2C):1127-30. Anticancer Res. 2004. PMID: 15154635 Free article.

10

Single-agent trastuzumab versus trastuzumab plus cytotoxic chemotherapy in metastatic breast cancer: a single-institution experience.

Köstler WJ, Steger GG, Krainer M, Kornek GV, Locker GJ, Brodowicz T, Marosi C, Singer CF, Hudelist G, Rabitsch W, Wiltschke C, Zielinski CC. Köstler WJ, et al. Among authors: steger gg. Anticancer Drugs. 2005 Feb;16(2):185-90. doi: 10.1097/00001813-200502000-00010. Anticancer Drugs. 2005. PMID: 15655416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters